Vaccine Induced Thrombotic Thrombocytopenia: What We Know & Don’t Know
This is a recorded version of the webinar on Vaccine Induced Thrombotic Thrombocytopenia: What We Know & Don’t Know that was presented live on Thursday, April 29, at 12:00 PM - 1:00 PM ET. Please scroll down to view the archived webinar.
Gowthami M. Arepally, MD
Professor of Medicine
Vice Chair of Research
Duke University Medicine
Roshni Kulkarni, MD (Moderator)
Former Director of Pediatric Hematology/Oncology
Michigan State University
This state-of-the-science Webinar detailed disseminated information related to the diagnosis and management of vaccine-induced immune thrombotic thrombocytopenia (VITT) post-vaccination. The Webinar featured a leading expert in the area of heparin-induced thrombocytopenia (HIT) who provided an overview of this emerging HIT-like disorder, as well as the most recent information regarding its background, diagnosis, and clinical management. The presentation was followed by a brief Q & A with the audience. Due to time constraints, Dr. Arepally did not respond to all of the questions submitted during the webinar. This document contains her responses to the questions that were not answered aloud during the webinar.
*Please note that the relevant data, treatment, and management of COVID-19 and VITT are changing constantly. Therefore, viewers should understand that the answers and views expressed by the faculty in this webinar as well as to questions asked during the live program are those of the faculty made at the time of the live program. Any information presented in any format by such speakers, without limitation, is for informational purposes only and FWGBD can make no representation as to the validity of any information contained within past the live viewing date. If you see any resources that are outdated or inaccurate, please let us know.
Target Audience: Hematologists, general practitioners, internists, nurse practitioners, and other healthcare professionals